CAS: 1884712-47-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | cpi-637 REF: IN-DA00ABS2CAS: 1884712-47-3 | % | To inquire | Wed 06 Nov 24 |
 | CPI-637 REF: TM-T6811CAS: 1884712-47-3 | 99.75% - 99.91% | 40.00 €~1,170.00 € | Wed 13 Nov 24 |
 | CPI-637 REF: 3D-JAD71247CAS: 1884712-47-3 | Min. 95% | To inquire | Wed 18 Dec 24 |
Ref: IN-DA00ABS2
| 50mg | 151.00 € | ||
| 100mg | 253.00 € | ||
| 250mg | 570.00 € |
Estimated delivery in United States, on Wednesday 6 Nov 2024
CPI-637
CAS:1884712-47-3
CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibitor.
Formula:
C22H22N6O
Purity:
99.75% - 99.91%
Color and Shape:
Solid
Molecular weight:
386.45
Ref: TM-T6811
| 1mg | 40.00 € | ||
| 2mg | 51.00 € | ||
| 5mg | 77.00 € | ||
| 10mg | 98.00 € | ||
| 25mg | 207.00 € | ||
| 50mg | 371.00 € | ||
| 100mg | 555.00 € | ||
| 500mg | 1,170.00 € |
Estimated delivery in United States, on Wednesday 13 Nov 2024
CPI-637
CAS:1884712-47-3
CPI-637 is a potential drug for the treatment of prostate cancer. It is a small …
Formula:
C22H22N6O
Purity:
Min. 95%
Molecular weight:
386.45 g/mol
Ref: 3D-JAD71247
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 18 Dec 2024
